English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 48 Help

Selected(0)Clear Items/Page:    Sort:
TCCIA: A comprehensive resource for exploring CircRNA in cancer immunotherapy Journal article
Wang, Shixiang, Xiong, Yi, Zhang, Yihao, Wang, Haitao, Chen, Minjun, Li, Jianfeng, Luo, Peng, Luo, Yung Hung, Hecht, Markus, Frey, Benjamin, Gaipl, Udo, Li, Xuejun, Zhao, Qi, Ma, Hu, Zhou, Jian Guo. TCCIA: A comprehensive resource for exploring CircRNA in cancer immunotherapy[J]. Journal for ImmunoTherapy of Cancer, 2024, 12(1), e008040.
Authors:  Wang, Shixiang;  Xiong, Yi;  Zhang, Yihao;  Wang, Haitao;  Chen, Minjun; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:10.3/11.6 | Submit date：2024/02/22
Biomarkers, Tumor  Genetic Markers  Immunotherapy  Tumor Biomarkers  
ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathway Journal article
Han, Meng-Ting, Pei, Hua, Sun, Qi-Qi, Wang, Cheng-Long, Li, Peng, Xie, Ya-Ya, Cao, Li-Jun, Zhang, Xing-Xing, Sun, Zhen-Liang. ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathway[J]. American Journal of Cancer Research, 2023, 13(4), 1533-1546.
Authors:  Han, Meng-Ting;  Pei, Hua;  Sun, Qi-Qi;  Wang, Cheng-Long;  Li, Peng; et al.
Favorite |   IF:3.6/4.5 | Submit date：2023/08/16
A global perspective on the ethnic-specific BRCA variation and its implication in clinical application Journal article
Wang，San Ming. A global perspective on the ethnic-specific BRCA variation and its implication in clinical application[J]. Journal of the National Cancer Center, 2023, 3(1), 14-20.
Authors:  Wang，San Ming
Favorite | TC[WOS]:4 TC[Scopus]:3 | Submit date：2023/08/03
BRCA variation  Cancer  Ethnicity  Evolution  Pathogenic  Population  
MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer Journal article
Fan,Jiansong, Zhang,Lei, Lv,Tianxu, Liu,Yuan, Sun,Heng, Miao,Kai, Jiang,Chunjuan, Li,Lihua, Pan,Xiang. MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer[J]. Journal of Cancer Research and Clinical Oncology, 2023, 149(11), 9229-9241.
Authors:  Fan,Jiansong;  Zhang,Lei;  Lv,Tianxu;  Liu,Yuan;  Sun,Heng; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:2.7/3.1 | Submit date：2023/08/03
Ancillary Diagnosis  Artificial Intelligence  Digital Pathology  Lymph Node And Distant Metastasis  Primary Breast Cancer  
A global perspective on the ethnic-specific BRCA variation and its implication in clinical application Review article
2022
Authors:  Wang, San Ming
Favorite | TC[WOS]:4 TC[Scopus]:3 | Submit date：2023/01/30
Brca Variation  Pathogenic  Ethnicity  Cancer  Population  Evolution  
Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population Journal article
Qin, Zixin, Li, Jiaheng, Tam, Benjamin, Sinha, Siddharth, Zhao, Bojin, Bhaskaran, Shanmuga Priya, Huang, Teng, Wu, Xiaobing, Chian, Jia Sheng, Guo, Maoni, Kou, Si Hoi, Lei, Huijun, Zhang, Li, Wang, Xiaoyu, Lagniton, Philip Naderev P., Xiao, Fengxia, Jiang, Xinyang, Wang, San Ming. Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population[J]. International Journal of Cancer, 2022, 152(6), 1159-1173.
Authors:  Qin, Zixin;  Li, Jiaheng;  Tam, Benjamin;  Sinha, Siddharth;  Zhao, Bojin; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:5.7/6.0 | Submit date：2023/01/30
Asian  Brca1  Brca2  Cancer  Database  Evolution  Germline Variation  Population  Structure  Variation  
MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2 Journal article
Jiang, Mengmeng, Yang, Yang, Niu, Liling, Li, Ping, Chen, Yibo, Liao, Ping, Wang, Yifei, Zheng, Jingbin, Chen, Fengyang, He, Huanhuan, Li, Hui, Chen, Xin*. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2[J]. Journal for ImmunoTherapy of Cancer, 2022, 10(11), e005241.
Authors:  Jiang, Mengmeng;  Yang, Yang;  Niu, Liling;  Li, Ping;  Chen, Yibo; et al.
Favorite | TC[WOS]:10 TC[Scopus]:9  IF:10.3/11.6 | Submit date：2022/12/01
Cd4-positive T-lymphocytes  Immunotherapy  Lymphocytes, Tumor-infiltrating  Tumor Microenvironment  
HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3 Journal article
Zang, Wei Jie, Hu, Yi Lin, Qian, Chen Yu, Feng, Ying, Liu, Jia Zhou, Yang, Jun Ling, Huang, Hua, Zhu, Yi Zhun, Xue, Wan Jiang. HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3[J]. British Journal of Cancer, 2022, 127(2), 237-248.
Authors:  Zang, Wei Jie;  Hu, Yi Lin;  Qian, Chen Yu;  Feng, Ying;  Liu, Jia Zhou; et al.
Favorite | TC[WOS]:26 TC[Scopus]:24  IF:6.4/8.1 | Submit date：2023/01/30
An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth Journal article
Ma, Guofang, Tan, Chengyue, Shan, Yaming, Shao, Ningyi, Wang, Feng, Dimitrov, Dimiter S., Wang, Liping, Zhao, Qi. An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth[J]. Journal of Cancer, 2022, 13(5), 1830-1836.
Authors:  Ma, Guofang;  Tan, Chengyue;  Shan, Yaming;  Shao, Ningyi;  Wang, Feng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:3.3/3.3 | Submit date：2022/05/17
Egfr  Gefitinib  Igf-i  Igf-ii  M708.5  Monoclonal Antibody  
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective Journal article
Chen, Yu Chi, Shi, Wei, Shi, Jia Jie, Lu, Jin Jian. Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective[J]. Journal of Cancer Research and Clinical Oncology, 2022, 148(1), 1-14.
Authors:  Chen, Yu Chi;  Shi, Wei;  Shi, Jia Jie;  Lu, Jin Jian
Favorite | TC[WOS]:28 TC[Scopus]:28  IF:2.7/3.1 | Submit date：2022/02/21
Anemia  Cd47/sirpα  Immunotherapy  Macrophages  Phagocytosis Checkpoint